baber/WOPTO huggingface dataset:
Patent CA-3095189-A1 (CA)
Title: Providing simulated lighting information for three-dimensional building models
Inventor: VINCENT JOSH
IPC: G06F30/13
Filed: 2020-10-05
Abstract: Techniques are described for using computing devices to perform automated operations related to, with respect to a computer model of a house or other building's interior, generating and displaying simulated lighting information in the model based on sunlight or other external light that is estimated to enter the building and be visible in particular rooms of the interior under specified conditions, such as using ambient occlusion and light transport matrix calculations. The computer model may be a 3D (three-dimensional) or 2.5D representation that is generated after the house is built and that shows physical components of the actual house's interior (e.g., walls), and may be displayed to a user of a client computing device in a displayed GUI (graphical user interface) via which the user specifies conditions for which the simulated lighting display is generated.
Patent CA-3096150-A1 (CA)
Inventor: AASUM ELISABETH
IPC: A23K50/80
Filed: 2019-04-10
Abstract: La présente invention concerne l'utilisation d'acide alpha-lipoïque comme additif alimentaire pour des animaux aquatiques tels que des poissons et des crevettes, en particulier des poissons d'eau froide comme par exemple le saumon, la brème, la perche et des poissons d'eau chaude comme la carpe, le tilapia et le poisson-chat. La présente invention concerne plus précisément l'utilisation d'acide alpha-lipoïque pour améliorer l'indice de consommation et/ou le gain journalier chez les poissons, pour réduire la mortalité par régulation de la microflore intestinale et/ou par protection de l'animal contre des infections provoquées par des virus pathogènes.
Patent CA-3096213-A1 (CA)
Inventor: JAIPAUL LARRY M
IPC: B66F13/00
Filed: 2020-10-15
Abstract: A portable vehicle lift and methods of using the same is provided. The lift includes a power system, a control system, one or more batteries, and a battery management system. The control system controls the power system. The one or more batteries powers the power system.  The battery management system (BMS) is configured to monitor data about the one or more batteries. The BMS may be configured to connect and/or disconnect the one or more batteries, or one or more individual battery cells, based on the data. The data may include current flowing into or out of the one or more batteries, the voltage of the one or more batteries, the level of charge of the one or more batteries, the temperature of the one or more batteries, the life expectancy of the one or more batteries, or the like.
Patent CA-3098552-A1 (CA)
Title: Processes for the preparation of zuclomiphene and intermediates thereof
Inventor: KARADEOLIAN AVEDIS
IPC: C07C25/24
Filed: 2020-11-09
Abstract: ABSTRACT The present invention provides processes for the preparation of zuclomiphene, as well as intermediates useful in the preparation thereof. In particular, processes are provided for the carbometallation of diphenylacetylene with a compound of Formula (3) to afford either zuclomiphene or an intermediate which is converted to zuclomiphene. A . Mx                                                          (3) Date Recue/Date Received 2020-11-09
Patent CA-3101350-A1 (CA)
Title: Procedes pour la separation de composants sanguins
Inventor: DORIAN RANDY
IPC: C12N5/078
Filed: 2019-06-27
Abstract: L'invention concerne un appareil et des procédés pour la séparation de composants sanguins, un appareil pour la séparation du sang comprenant d'une manière générale un tube définissant un canal et conçu pour recevoir une quantité de sang et un flotteur contenu à l'intérieur du tube et ayant une densité prédéfinie de telle sorte que le flotteur est maintenu à l'équilibre entre une première couche formée à partir d'une première composante fractionnaire du sang et une seconde couche formée à partir d'une seconde composante fractionnaire du sang. La première couche peut être retirée du tube, une fois la centrifugation achevée, tandis que le flotteur isole la seconde couche de la première couche.
Patent CA-3106163-A1 (CA)
Inventor: OSBORN SCOTT E
IPC: C08K3/08
Filed: 2019-07-12
Abstract: The present disclosure relates to polymer resins, fibers, and yarns with permanent antimicrobial activity, and a method of producing the same. In one embodiment, the antimicrobial polymer resin comprises a polymer having less than 2500 ppm of zinc dispersed within the polymer, less than 1000 ppm of phosphorus, wherein the weight ratio of zinc to phosphorus is at least 1.3:1 or less than 0.64:1.
Patent CA-3106453-A1 (CA)
Title: Enzymatic hydrolysis of fucans
Inventor: BORASTON ALISDAIR
IPC: C12N15/56
Filed: 2019-07-24
Abstract: Fucanases from Psychromonas species, including P5AFcnA fucanase and P19DFcnA fucanase. Also, methods, systems, compositions, etc., related thereto including fucan compositions having reduced average molecular weight after hydrolysis by such fucanases.
Patent CA-3107527-A1 (CA)
Inventor: MURCH LUKE
IPC: A45D8/30
Filed: 2021-01-29
Abstract: This product is comprised of an over the head band with a stem branching off of the middle holding the band off of the top of your hair, as well as a comb like item to hold the sides of your hair back. This products use is specifically to hold back the sides of your hair to maintain a tidy and natural look of your hair flowing backward. The combs on the side push your hair back in a natural manner, with a size to cover the sides of your head evenly. The side pieces sit off of your head due to the bristles holding your hair back, which stops your hair from being pressed against the side of your head in an unnatural looking way. This product creates a natural, tidy look for medium to long hair so it will all flow backward without sticking out at the sides.
Patent CA-3108842-A1 (CA)
Title: Recombinant lectin variants
Inventor: SATHE DHANANJAY
IPC: C07K14/705
Filed: 2019-08-30
Abstract: A modified lectin protein is provided having at least one amino acid modification in an amino acid sequence of SEQ ID NO. 1 orin an amino acid sequence having at least 60% homologythereto. The amino acid modification is selected from one of more of the following: at least one amino acid modification in a carbohydrate binding site; at least one amino acid modification in the N-terminus;at least one amino acid modification at position 76; or at least one amino acid modification at position 44 or 89. The modified lectin protein does not consist of the amino acid sequence of any of SEQ ID NOs: 2 to 4.
Patent CA-3109764-A1 (CA)
Inventor: DICKIE PAIGE ELYSE
IPC: G06Q10/04
Filed: 2021-02-22
Abstract: The disclosed embodiments include computer-implemented apparatuses and processes that dynamically predict future occurrences of events using adaptively trained machine-learning or artificial-intelligence processes. For example, an apparatus may generate an input dataset based on first interaction data associated with a prior temporal interval, and may apply an adaptively trained, gradient-boosted, decision-tree process to the input dataset. Based on the application of the adaptively trained, gradient-boosted, decision-tree process to the input dataset, the apparatus may generate output data representative of a predicted likelihood of an occurrence of an event during a future temporal interval, which may be separated from the prior temporal interval by a corresponding buffer interval. The apparatus may also transmit a portion of the generated output data to a computing system, and the computing system may be configured to generate or modify second interaction data based on the portion of the output data.
Patent CA-3111079-A1 (CA)
Inventor: STOOF JOHAN JOHANNES
IPC: B27F7/38
Filed: 2019-09-13
Abstract: An automated lift machine that feeds strips of staples into an automated stapling machine that can be used in a production line. The lift machine includes a lifter subassembly and a pusher subassembly, and a magazine for holding multiple strips of staples that are stacked on top of one another. A lift fork extends under of the legs of the second staple strip from the bottom, then lifts up all of the stacked staples in the magazine except for the bottom-most staple strip. After that occurs, the pusher forces the bottom-most staple strip from beneath the stacked staples in the magazine, then pushes that strip toward an exit position, into the feeder for the automated stapling machine. The pusher retracts and the lift fork gently lowers the stacked staples in the magazine until they bottom out, after which the lift fork retracts from the stack.
Patent CA-3111508-A1 (CA)
Title: Non-invasive and minimally invasive laser surgery for the reduction of intraocular pressure in the eye
Inventor: RAKSI FERENC
IPC: A61F9/008
Filed: 2019-07-19
Abstract: Intraocular pressure in an eye is reduced by delivering a high resolution optical coherence tomography (OCT) beam and a high resolution laser beam through the cornea, and the anterior chamber into the irido-corneal angle along an angled beam path. The OCT beam provides OCT imaging for surgery planning and monitoring, while the laser beam is configured to modify tissue or affect ocular fluid by photo- disruptive interaction. In one implementation, a volume of ocular tissue within an outflow pathway in the irido-corneal angle is modified to create a channel opening in one or more layers of the trabecular meshwork. In another implementation, a volume of fluid in the Schlemm's canal is affected by the laser to bring about a pneumatic expansion of the canal. In either implementation, resistance to aqueous flow through the eye is reduced.
Patent CA-3117685-A1 (CA)
Inventor: RAFFEL GLEN
IPC: A61K39/395
Filed: 2019-10-31
Abstract: Provided herein are compositions and methods useful for the transplantation of hematopoietic stem and progenitor cells, as well as for preparing patients for receipt of such therapy, such as patients suffering from a variety of inherited metabolic disorders.
Patent CA-3118488-A1 (CA)
Inventor: SPEAKE JASON D
IPC: A61K31/52
Filed: 2019-11-04
Abstract: The present invention describes novel compounds, or their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their medical uses. The compounds of the invention have activity as Janus Kinase inhibitors and are useful in the treatment or control of pruritus, associated with allergic dermatitis, atopic dermatitis in animals, and other disorders and indications where immunosuppression/immunomodulation would be desirable. Also described herein are methods of treating pruritus and atopic dermatitis by administering the compounds of the invention, which are JAK 1 inhibitors.
Patent CA-3118982-A1 (CA)
Inventor: MOUSSON PIERRE JACQUES
IPC: B31C3/00
Filed: 2019-11-12
Abstract: L'invention concerne un système comprenant un mandrin, un dispositif d'enroulement pour enrouler de manière hélicoïdale des bandes autour du mandrin pour former un tube de base s'éloignant du mandrin à une vitesse de tube, un dispositif d'apport de bande pour amener les bandes au dispositif d'enroulement, et un dispositif de coupe pour découper le tube de base à une longueur prédéterminée pour former les tronçons de tube pendant que le tube de base se déplace dans une direction de tube à la vitesse de tube, et un procédé correspondant.
Patent CA-3119425-A1 (CA)
Title: Externally programmable magnetic valve assembly and controller
Inventor: HAKIM CARLOS A
IPC: A61M27/00
Filed: 2021-05-17
Abstract: An externally programmable shunt valve assembly that includes a motor having a rotor that is operable in response to an externally applied magnetic field and configured to increase or decrease the working pressure of the shunt valve assembly. The motor may further include a position sensing mechanism that allows a position of the rotor, and associated pressure setting of the valve, to be determined using an external magnetic sensor. In certain examples the motor further includes a mechanical brake that is magnetically operable between a locked position and an unlocked position and which, in the locked position, prevents rotation of the rotor.
Patent CA-3121910-A1 (CA)
Title: Inhibitors of apol1 and methods of using same
Inventor: BRODNEY MICHAEL
IPC: A61P13/12
Filed: 2019-12-17
Abstract: The disclosure provides at least one entity chosen from compounds of formula (I), solid state forms of the same, compositions comprising the same, and methods of using the same, including use in treating focal segmental glomerulosclerosis (FSGS) and/or non-diabetic kidney disease (NDKD).
Patent CA-3122238-A1 (CA)
Inventor: SHOCKLEY BRETT
IPC: H04L9/06
Filed: 2019-12-05
Abstract: Les techniques de l'invention concernent de manière générale un réseau de gestion de données "à connaissance nulle". Des utilisateurs peuvent partager une preuve vérifiable de données et/ou d'informations d'identité, et les entreprises peuvent demander, consommer, et agir sur les données, tout cela sans qu'un serveur de stockage de données ou ces entreprises ne voient jamais les informations sensibles brutes (des données stockées par un serveur étant visibles uniquement par les destinataires prévus, pouvant même être sélectionnées après stockage) ou n'aient jamais accès à celles-ci. Dans un mode de réalisation, des données sources sont chiffrées avec une clé de chiffrement source (par exemple, clé publique source), une clé de remise à la clé étant une combinaison de chiffrement d'une clé de déchiffrement source (par exemple, clé privée source) et d'une clé publique du destinataire. Sans pouvoir déchiffrer les données, le serveur de stockage peut utiliser la clé de remise à la clé pour rechiffrer les données sources avec la clé publique du destinataire, pour être ensuite déchiffrées uniquement par le destinataire correspondant à l'aide de sa clé privée, en conséquence.
Patent CA-3123979-A1 (CA)
Inventor: CAO ZHUOXIAO
IPC: A61P3/10
Filed: 2019-12-20
Abstract: Provided are a human GCGR antibody, a GLP-1 peptide and a mutant thereof, as well as a bispecific protein formed by fusion of the GCGR antibody and the GLP-1 peptide and a preparation method therefor, which may be used for weight loss and diabetes treatment.
Patent CA-3124349-A1 (CA)
Title: System and method of real-time wiki knowledge resources
Inventor: GORNY THOMAS
IPC: G06Q10/00
Filed: 2019-11-21
Abstract: A system and method are disclosed for recommending a resource to a customer service representative that includes one or more databases that store data describing electronic communication between one or more customer system communication devices and one or more service center communication devices. Embodiments further include a computer coupled with one or more databases and configured to monitor communication activity to determine whether a customer service ticket has been opened between one or more customer system communication devices and one or more service center communication devices and determine a customer service representative score based on one or more customer service representative ranking factors.
Patent CA-3125782-A1 (CA)
Title: Biomarker monitoring sensor and methods of use
Inventor: BTEICH MOUSSA
IPC: G01R27/26
Filed: 2020-02-28
Abstract: Provided herein are systems, methods and apparatuses for a Biomarker sensor.
Patent CA-3129651-A1 (CA)
Inventor: JOORIS DIANE
IPC: A61B5/374
Filed: 2020-02-07
Abstract: L'invention concerne un procédé mis en uvre par ordinateur pour déterminer et/ou surveiller un niveau d'état de conscience modifié d'un sujet recevant une session de traitement comprenant la modification de l'état de conscience du sujet non pharmacologiquement, le procédé consistant à : recevoir des données de réponse représentant la réponse d'un sujet à la session de traitement, les données de réponse comprenant des données mesurées comprenant des données d'électroencéphalogramme, EEG, les données d'EEG comprenant : des données collectées à partir d'au moins l'une parmi : au moins une électrode d'EEG frontale (F) située sur la région anatomique du cuir chevelu correspondant à un lobe frontal du sujet, et au moins une électrode d'EEG pariétale (P) située sur la région anatomique du cuir chevelu correspondant à un lobe pariétal du sujet ; déterminer, à partir des données de réponse, le niveau d'état de conscience modifié d'un sujet du sujet.
Patent CA-3130563-A1 (CA)
Title: System and method for enhanced imaging of biological tissue
Inventor: GAMLIEL AVIHU MEIR
IPC: G01J3/36
Filed: 2020-03-11
Abstract: A system and method are presented for use in angiographic imaging. The system comprises: a light source unit, and at least one imaging unit comprising a detector array, wherein the detector array comprises at least first and second types of detector cells having corresponding first and second different spectral response functions defining respectively first and second spectral peaks; and the light source is unit configured for emitting light formed of at least first and second discrete wavelength ranges which are selected to be aligned with said first and second spectral peaks of said first and second types of detector cells.
Patent CA-3133353-A1 (CA)
Inventor: ADAMS JERAMIE JOSEPH
IPC: C08L95/00
Filed: 2020-03-12
Abstract: Methods for of processing an oxygen containing feedstock to an amine reacted liquid or solid phase with a different solubility, polarity and/or functionality may, in various embodiments, comprise steps of contacting the amine with an oxygen containing hydrocarbon with temperature to facilitate reactions to reduce the oxygen content and modulate the solubility, polarity and/or functionality of the products.
Patent CA-3135064-A1 (CA)
Title: Formulations
Inventor: FOGEL BARRY S
IPC: A61K9/20
Filed: 2020-04-02
Abstract: L'invention concerne des formulations à dose élevée d'acamprosate sous une forme de sel pharmaceutiquement acceptable, ainsi que des procédés de préparation celles-ci et des méthodes d'utilisation de celles-ci.
Patent CA-3135508-A1 (CA)
Inventor: CHEN BANGCHI
IPC: C07C255/31
Filed: 2019-04-01
Abstract: Provided by the present invention are a novel halogenated conjugated diene compound 1, a preparation method therefor and use thereof. The compound 1 can be obtained by subjecting a conjugated diene compound as a raw material to halogenation. 2-arylmalonic acid derivative obtained by subjecting compound 1 to dehydrohalogenation and aromatization can be applied to the synthesis of biologically active compounds. The present invention has the following significant features and advantages: (1) the present invention provides a novel halogenated conjugated diene compound 1 and a synthesis method therefor; and (2) this kind of multifunctional novel compounds 1 can be used to synthesize other compounds of significant value by means of further functionality conversion reactions.
Patent CA-3136243-A1 (CA)
Title: Nano ou microparticules proteiques utilisees en tant que corps d'inclusion artificiels
Inventor: VILLAVERDE CORRALES ANTONIO
IPC: C07K14/00
Filed: 2020-04-08
Abstract: L'invention concerne des particules protéiques comprenant un agrégat d'un ou plusieurs types de protéines indépendantes assemblées. La particule a une taille de 50 nm à 50 micromètres ; se présente sous la forme d'une pastille dans un milieu aqueux ; est mécaniquement stable ; et libère un pourcentage en poids particulier de la protéine indépendante dans une période de temps prédéfinie, et de tout autre composé contenu dans la particule. L'invention concerne également des procédés particuliers permettant d'obtenir les particules, lesdits procédés comprenant l'ajout de sels pour permettre la précipitation de protéines. L'invention concerne également des particules protéiques particulières comprenant des lipides associés à l'assemblage de protéines indépendantes. L'invention concerne également plusieurs utilisations de la particule, en particulier des utilisations médicales et des compositions pharmaceutiques et cosmétiques comprenant les particules.
Patent CA-3137198-A1 (CA)
Title: Fxr small molecule agonist and preparation method therefor and use thereof
Inventor: XU HUAQIANG
IPC: A61P29/00
Filed: 2020-04-20
Abstract: An FXR small molecule agonist and a preparation method therefor and a use thereof, having a structure as shown in formula (I). The compound represented by formula (I) has FXR agonistic activity and is capable of preparing drugs for treatment of FXR-related diseases.
Patent CA-3137757-A1 (CA)
Inventor: CHATTERJEE JOON
IPC: G16H40/40
Filed: 2020-05-07
Abstract: La présente invention concerne un capteur (par ex. un capteur optique) qui peut être implanté dans un animal vivant (par ex. un être humain) et peut être utilisé pour mesurer un analyte (par ex. le glucose ou l'oxygène) dans un milieu (par ex. le liquide interstitiel, le sang ou le liquide intrapéritonéal) dans l'animal.<i /> <i /> <i /> <i /> Le capteur peut comprendre un boîtier de capteur, un indicateur d'analyte recouvrant au moins une partie du boîtier de capteur, et un ou plusieurs composés ayant des fractions contenant un groupe dithio, thio ou mercapto qui réduisent la dégradation de l'indicateur d'analyte.
Patent CA-3140259-A1 (CA)
Inventor: LANARO ALESSANDRO
IPC: G02C5/22
Filed: 2021-11-23
Abstract: Spectacle frame (1) comprising: a front piece (10); a pair of temples (20), each temple(20) extending between a first end portion (21) associated with the front piece (10) and a second end portion (22) that can be positioned on the ear of a user; a pair of hinges (30) configured to rotationally bind each temple(20) to the front piece (10), each hinge (30) comprising: a pin (40) extended along a development direction (A-A) between a first end (40a) and a second end (40b), coupling devices (50) associated with the first end portion (21) of each temple(20) and configured to engage the corresponding pin (40); a cavity (60) located in the front piece (10), the cavity (60) comprising: a first wall (70) and an opposite second wall (80) spaced along a spacing direction (B-B); and blocking devices (90) configured to engage the ends (40a, 40b) of the pins (40), the blocking devices (90) being shaped to match the first end (40a) and the second end (40b) of the pin (40) to prevent the pin (40) from making rotational movements around the development axis (A-A) and translational movements with respect to the blocking devices (90) as a result of mutual engagement between the ends (40a, 40b) of the pin (40) with the blocking devices (90); the first end (40a) and the second end (40b) of the pin (40) are wedge-shaped.
Patent CA-3140735-A1 (CA)
Title: Compositions and methods using trigonelline and vitamins for preventing or treating conditions or disorders in skeletal muscle
Inventor: FEIGE JEROME
IPC: A61K31/455
Filed: 2020-07-03
Abstract: The present invention relates to compositions and methods for preventing or treating skeletal muscle conditions or diseases. The present invention also relates to compositions and methods that help to increase NAD+ levels in skeletal muscle. Preferably, the present invention relates to compositions and methods that use trigonelline and vitamins selected from the group consisting of: Vitamin D, Vitamin B12, B3, B6, B7, Vitamin C and/or Vitamin E for preventing or treating skeletal muscle conditions or diseases. The recipient of the compositions of the invention can be, for example, an elderly individual or an individual with sarcopenia or an individual in need of the compositions and methods of the invention for recovery of skeletal muscles, for example, after exercise, muscle injury or surgery.